SlideShare a Scribd company logo
1 of 74
Food Allergy &
Food Intolerance

Diagnostic algorithm for
Celiac Disease
Dr Ashok Rattan, MD, MAMS
Chief Operating Officer & Medical Director,
Star Metropolis Clinical Lab
Dubai, Sharjah, Abu Dhabi
Diagnostic Algorithm for Celiac Disease
Food Allergy Vs Food
intolerance
Definition of Food Allergy ?

Definition of Food Allergy
Food allergy has no universally accepted
definition. The NIAID has suggested
that food allergy be defined as

•“Adverse immune response that occurs
reproducibly on exposure to a given food and is
distinct from other adverse responses to food,
such as, food intolerance, pharmacologic
reactions or toxin mediated reactions”
Signs & Symptoms of Food Allergy

ATOPY
Type 1
Hypersensitivity
Possible
Food allergy & “Intolerance”
Type of Reaction

Cause

Food Involved

Allergy

Atophy, IgE mediated

Eggs, Milk, Wheat, Fish,
Shellfish, Nut, Peanuts, Soya

Pharmacological

Absorption of certain
amines from food

Fermented food (cheese, red
wine, sausages) fish

Enzyme defects

Failure of normal
enzymatic breakdown
after absorption

Methanol, Lactose

Irritant

Reflux

Strong spices

Toxic

Toxins

Some shellfish, Mushroom,
badly stored food

Chemicals

MSD, Sulfites

Chinese food, dry fruits

Celiac disease

IgG to Gliadin,
auto-immune

Wheat, Maize, Rye

Psychological

Emotional reaction to
food
Food proteins are recognized as “foreign”
Food specific IgG production and formation of
antigen/antibody complexes
Complexes are deposited in tissues and activate
Complement
Complement and macrophages stimulate
Inflammation
Delayed reaction and may last for days
Food Allergy

Food Intolerance
Signs & Symptoms of Food Intolerance
Class 0
Classes 1-2

No allergic reaction against tested food.
No restriction is necessary.
Means that there is a low to moderate
allergic reaction against tested food.
These have to be avoided for 12 weeks.

Class 3

There is a major allergy type III against
the tested foods. Strict avoidance for
6 months.

Class 4

There is a major allergy type III against
the tested foods. Strict avoidance for
1 year.
Improvement of symptoms (%)
after omitting allergenic food

Study, 2002-2008; evaluated by Mediveritas Institiute for Medical Studies, Munich

30
Celiac Disease
• Samuel Gee (1888) first described Celiac disease
in “On the Coelic Affection”
– Gluten sensitive entropathy
– Nontropical sprue

• Aretaeus from Cappadocia (now Turkey)
described similar malabsorption disorder in
second century AD
Celiac disease
“There is a kind of chronic indigestion
which is met with in persons of all ages,
yet is especially apt to affect children
between one and five years old .
Signs of the disease are yielded by the fæces; being
loose, not formed, but not watery; more bulky than
the food taken would seem to account for; pale in
colour, as if devoid of bile; yeasty, frothy, an
appearance probably due to fermentation; stinking,
stench often very great, the food having undergone
putrefaction rather than concoction".
What is celiac disease ?
• Chronic inflammatory disease primary
affecting small intestine
• Results from inflammatory response initiated
by dietary gluten
• Inflammation leads to damage and atrophy of
intestinal villae
Clinical features
Consequence of intestinal inflammation & atrophy
• Common clinical symptoms
– Abdominal pain
– Diarrhea / vomiting
nonspecific
– Failure to thrive/malnutrition
• Comorbid conditions
– Immunologic abnormalities
• Selective IgA deficiency

– Autoimmune endocrine disorders
• Type 1 diabetes

– Dermatologic disorders
How common is it ?
World Wide Prevalence
Celiac Disease can present at ANY age to
ANY specialty
Farrell RJ & Kelly CP: New Engl J Med 2002; 336: 180 - 188
Cause of celiac disease
• Willem K Diche recognized association
between consumption of bread & relapsing
diarrhoea
• WW 2: unconventional, non-cereal foods
– Fruits, potatoes, banana, milk or meat

• After WW 2, symptoms reappeared
cereals
Deamidated Gliadin
Role of tTG in Celiac Disease
Endomycial antibodies
HLA & Celiac Disease
Useful for ruling out celiac disease
Development of celiac disease
• Environmental component
– Exposure to cereal grain proteins
• Wheat, barley, rye [gluten]

• Genetic component
– Family members of individuals
– HLA DQ 2 or HLA DQ 8
Auto Immune Reaction
Dermatitis Herpetiformis
(Duhring’s disease)
Dermatitis Herpetiformis
(Duhring’s disease)

•
•
•
•
•
•
•

Chronic blistering skin condition
No virus involved
Autoantibodies present, gluten intolerance
Affects both male & females, 15 to 40 yrs of age
Intensively itchy, chronic papulo-vesicular rash
EMA positive (IFA): Ig A isotype
eTG (epidermal Transglumase) positive IgG /
IgA
• HLA DQ 2
Ciliac Disease Histopathology

Normal small bowel mucosa

Small bowel mucosa in celiac disease showing
subtotal villus atrophy.
Diagnosis
• Presumptive diagnosis
– Positive serology
– Intestinal biopsy with villous atrophy

• Definitive diagnosis
– Resolution of clinical symptoms after initiation of
gluten free diet
• Generally accompanied by conversion to negative
serology & reconstitution of villi
Laboratory Diagnosis of Celiac Disease
Milestones
• Before 1960: based on clinical suspicion & biopsy
• 1982: Anti gliadin; Sensitivity: 70%; Specificity 70%
• 1985: Endomysial IFA; Sen: 70 – 90%; Specificity 100%
• 1997: Anti tTG by ELISA; Sen & Spec: 90 – 95%
• 2005: Anti deamidated Gliadin: Sen: 85%, Spec 90%
Serologic tests for celiac disease
2014
• Tissue transglutaminase antibodies
– IgA and IgG isotypes [ELISA]

• Deamidated gliadin antibodies
– IgA and IgG isotypes [ELISA]

• Endomysial antobodies
– IgA isotype only by IFA
Other investigations
• HLA DQ typing
• Small intestinal biopsy
• Total IgA
Test for selective IgA deficiency
1.

Normal Total IgA

CD unlikely
HLA DQ2 & DQ8
Negative

Deamidated Gliadin IgA & IgG
EMA IgA
+/+, +/-,-/+

-/-

Positive
CD unlikely

S.I Biopsy
2.

IgA detectable but below RR

HLA DQ 2 & DQ 8
3.

Undetectable Total Ig A

• Selective IgA deficiency
• Test for tTG
• Test for Deamidated Gliadin
– Both for IgG isotype only

• If positive advice small intestinal biopsy
Summary
• Total IgA

– Identify individuals with selective IgA deficiency

• Anti TTG & Anti deamidated gliadin antibodies
• IgA & IgG isotypes
• Anti EMA IgA isotype by IFA

• Identify individuals with suspected celiac disease
• Confirm with small intestine biopsy

– Specific antibodies may be absent if on gluten free
diet

• HLA DQ 2 & HLA DQ 8

– Negative results virtually excludes diagnosis of CD
Additional tests that need to be
carried out
•
•
•
•
•
•
•
•

CBC
TSH
LFT
Vitamins: D, A, E, K, Folate, B12
Calcium, Phosphate, Zinc
PTH
Iron studies
Bone Mineral Density Scan
Who should be tested ?

Rubio Tapia R et al: Am J Gastro 2013: 108: 656 – 76
American Gastroenterology Society Recommendations

• Consider testing in
symptomatic patients at
high risk of
– Autoimmune Hepatitis
– Premature onset
osteoprosis
– Primary Biliary cirrhosis
– Unexplained increase in
liver transaminases
– Unexplained iron
deficiency anemia

• Consider testing for CD when
following are present:
– Autoimmune Thyroid
disease
– Cerebellar Ataxia
– 1st & 2nd degree relatives
– IBS
– Peripheral neuropathies
– Selective IgA deficiency
– Type 1 diabetes
– Turner & Down syndrome
Who should be tested ?
ESPGHAN Guidelines for Celiac Disease 2012

European Society for pediatric gastroenterology, hepatology and nutrition

• Group 1
– Children & adolescents with
otherwise unexplained
symptoms & signs of
• Chronic or intermittent
diarrhea
• Failure to thrive / Weight
loss/ Stunted growth
• Delayed puberty /
Amenorrhea
• Iron deficiency anemia
• Nausea or vomiting
• Abdominal pain, cramping
or distention
• Chronic fatigue
• Recurrent aphthous ulcer

• Group 2
– Asymptomatic children &
adolescent with
• Type 1 diabetes
• Down syndrome
• Autoimmune thyroid
disease
• Turner syndrome
• Selective IgA deficiency
• Autoimmune liver disease
• First degree relatives of
Celiac disease patients
A simple scoring system
ESPGHAN Guidelines for Celiac Disease 2012

European Society for pediatric gastroenterology, hepatology and nutrition

Elements (Need Score of 4 for diagnosis)

Score

Symptoms:
Malabsorption
Other CD relevant symptoms or TIDM or 1st degree relative
Asymptomatic

2
1
0

Serum antibodies
EMA positivity and/or high positivity for anti tTG
Low positivity for tTG or isolated anti DGP positivity
Serology not performed
Serology performed but all celiac specific antibodies negtive

2
1
0
-1

HLA
Full HLA DQ 2 or HLA 8 hetrodimer present
No HLA performed or half DQ 2 present
HLA neither DQ 2 or DQ 8

1
0
-1

Histology
Marsh 3b or 3c (subtotal villous atrophy, flat lesion)
Marsh 2 or 3a (moderate decreased villous height) plus tTG antibodies
Marsh 0 – 1 or no biopsy performed

2
1
0
One man’s alloo paratha maybe
another man’s poison
Caution

ESPGHAN Guidelines for Celiac Disease 2012

European Society for pediatric gastroenterology, hepatology and nutrition

• A gluten free diet (GFD) should be introduced
only after the completion of the diagnostic
process and when a conclusive diagnosis has
been made.
• Healthcare professionals should be advised
that starting patients on a GFD, when CD has
not been excluded or confirmed, may be
detrimental.
Celiac disease diagnosis algorithm
Celiac disease diagnosis algorithm

More Related Content

What's hot (20)

Fatimah & amal : celiac disease
Fatimah & amal : celiac diseaseFatimah & amal : celiac disease
Fatimah & amal : celiac disease
 
Celiac disease truths n myths
Celiac disease  truths n mythsCeliac disease  truths n myths
Celiac disease truths n myths
 
Celiac disease
Celiac diseaseCeliac disease
Celiac disease
 
CELIAC DISEASE
CELIAC DISEASECELIAC DISEASE
CELIAC DISEASE
 
Celiac disease copy
Celiac disease   copyCeliac disease   copy
Celiac disease copy
 
Celiac Disease
Celiac DiseaseCeliac Disease
Celiac Disease
 
Celiac disease
Celiac diseaseCeliac disease
Celiac disease
 
Celiac disease most under diagnosed health problem
 Celiac disease most under diagnosed health problem Celiac disease most under diagnosed health problem
Celiac disease most under diagnosed health problem
 
Celiac disease
Celiac diseaseCeliac disease
Celiac disease
 
approach to a patient with Chronic diarrhoea
approach to a patient with Chronic diarrhoeaapproach to a patient with Chronic diarrhoea
approach to a patient with Chronic diarrhoea
 
Celiac disease
Celiac diseaseCeliac disease
Celiac disease
 
Celiac disease
Celiac disease Celiac disease
Celiac disease
 
A glance on celiac disease
A glance on celiac diseaseA glance on celiac disease
A glance on celiac disease
 
Ulcerative colitis
Ulcerative colitisUlcerative colitis
Ulcerative colitis
 
Celiac disease
Celiac diseaseCeliac disease
Celiac disease
 
Celiac disease
Celiac diseaseCeliac disease
Celiac disease
 
Celiac disease
Celiac diseaseCeliac disease
Celiac disease
 
Aproach to child with vomiting
Aproach to child with vomitingAproach to child with vomiting
Aproach to child with vomiting
 
Celiac Disease, Gluten Sensitivity_Dr. Scot Lewey
Celiac Disease, Gluten Sensitivity_Dr. Scot LeweyCeliac Disease, Gluten Sensitivity_Dr. Scot Lewey
Celiac Disease, Gluten Sensitivity_Dr. Scot Lewey
 
GASTRITIS.pptx
GASTRITIS.pptxGASTRITIS.pptx
GASTRITIS.pptx
 

Viewers also liked

Viewers also liked (14)

Celiac disease
Celiac diseaseCeliac disease
Celiac disease
 
Celiac disease
Celiac diseaseCeliac disease
Celiac disease
 
Celiac disease
Celiac diseaseCeliac disease
Celiac disease
 
Celiac disease
Celiac diseaseCeliac disease
Celiac disease
 
celiac disease
celiac diseaseceliac disease
celiac disease
 
Celiac disease
Celiac diseaseCeliac disease
Celiac disease
 
Chap19b Acquired Immune Response
Chap19b Acquired Immune ResponseChap19b Acquired Immune Response
Chap19b Acquired Immune Response
 
Fungal infections part II
Fungal infections part IIFungal infections part II
Fungal infections part II
 
Febrile neutropenia---paediatrics
Febrile neutropenia---paediatricsFebrile neutropenia---paediatrics
Febrile neutropenia---paediatrics
 
Fungal infections part III
Fungal infections part IIIFungal infections part III
Fungal infections part III
 
H pylori resistance
H pylori resistanceH pylori resistance
H pylori resistance
 
Febrile neutropenia in chidren
Febrile neutropenia in chidrenFebrile neutropenia in chidren
Febrile neutropenia in chidren
 
Ftt
FttFtt
Ftt
 
Malabsorption syndromes
Malabsorption syndromesMalabsorption syndromes
Malabsorption syndromes
 

Similar to Celiac disease diagnosis algorithm

Celiac disease in children 2021
Celiac disease in children 2021Celiac disease in children 2021
Celiac disease in children 2021Imran Iqbal
 
Celiac disease power point presentation
Celiac disease  power point presentationCeliac disease  power point presentation
Celiac disease power point presentationdrbeenaMemon
 
CELIAC DISEASE1.pptx
CELIAC DISEASE1.pptxCELIAC DISEASE1.pptx
CELIAC DISEASE1.pptxShubhendra4
 
Celiac for patients - Dr. Vishnu Biradar
Celiac for patients - Dr. Vishnu BiradarCeliac for patients - Dr. Vishnu Biradar
Celiac for patients - Dr. Vishnu Biradaramol1713
 
Steatorrhea, Chyluria, Gallstone (Cholelithiasis), Pancreatitis (Chronic and ...
Steatorrhea, Chyluria, Gallstone (Cholelithiasis), Pancreatitis (Chronic and ...Steatorrhea, Chyluria, Gallstone (Cholelithiasis), Pancreatitis (Chronic and ...
Steatorrhea, Chyluria, Gallstone (Cholelithiasis), Pancreatitis (Chronic and ...akash mahadev
 
Celiac disease 2020
Celiac disease 2020Celiac disease 2020
Celiac disease 2020Imran Iqbal
 
CELIAC DISEASE by Dr Asad Abbasi.pptx
CELIAC DISEASE by Dr Asad Abbasi.pptxCELIAC DISEASE by Dr Asad Abbasi.pptx
CELIAC DISEASE by Dr Asad Abbasi.pptxMuhammad Asad
 
Celiac Disease vs Non Celiac Gluten Sensitivity 3
Celiac Disease vs Non Celiac Gluten Sensitivity 3Celiac Disease vs Non Celiac Gluten Sensitivity 3
Celiac Disease vs Non Celiac Gluten Sensitivity 3Emily Hullinger
 
The Role of Food Sensitivity and Food Intolerance Tests
The Role of Food Sensitivity and Food Intolerance TestsThe Role of Food Sensitivity and Food Intolerance Tests
The Role of Food Sensitivity and Food Intolerance TestsAlcat Test
 
Lewis_Carly_ClinicalCaseStudy
Lewis_Carly_ClinicalCaseStudyLewis_Carly_ClinicalCaseStudy
Lewis_Carly_ClinicalCaseStudyCarly Lewis
 
Food intolerence
Food intolerenceFood intolerence
Food intolerenceAzad Haleem
 
Gluten intolerance and rheumatic diseases 5.2.14
Gluten intolerance and rheumatic diseases 5.2.14Gluten intolerance and rheumatic diseases 5.2.14
Gluten intolerance and rheumatic diseases 5.2.14IFSMED
 
The Scoop on Gluten Free: Research & Practice Tips
The Scoop on Gluten Free: Research & Practice TipsThe Scoop on Gluten Free: Research & Practice Tips
The Scoop on Gluten Free: Research & Practice Tipsmilfamln
 
celiac disease 0r gluten enteropathy ppty
celiac disease 0r gluten enteropathy pptyceliac disease 0r gluten enteropathy ppty
celiac disease 0r gluten enteropathy pptyAnnaKhurshid
 

Similar to Celiac disease diagnosis algorithm (20)

Celiac4residents - 1-30-2019
Celiac4residents - 1-30-2019Celiac4residents - 1-30-2019
Celiac4residents - 1-30-2019
 
Celiac disease in children 2021
Celiac disease in children 2021Celiac disease in children 2021
Celiac disease in children 2021
 
Celiac disease power point presentation
Celiac disease  power point presentationCeliac disease  power point presentation
Celiac disease power point presentation
 
CELIAC DISEASE1.pptx
CELIAC DISEASE1.pptxCELIAC DISEASE1.pptx
CELIAC DISEASE1.pptx
 
Celiac disease
Celiac diseaseCeliac disease
Celiac disease
 
Celiac for patients - Dr. Vishnu Biradar
Celiac for patients - Dr. Vishnu BiradarCeliac for patients - Dr. Vishnu Biradar
Celiac for patients - Dr. Vishnu Biradar
 
Celiac Disease
Celiac DiseaseCeliac Disease
Celiac Disease
 
Steatorrhea, Chyluria, Gallstone (Cholelithiasis), Pancreatitis (Chronic and ...
Steatorrhea, Chyluria, Gallstone (Cholelithiasis), Pancreatitis (Chronic and ...Steatorrhea, Chyluria, Gallstone (Cholelithiasis), Pancreatitis (Chronic and ...
Steatorrhea, Chyluria, Gallstone (Cholelithiasis), Pancreatitis (Chronic and ...
 
Celiac disease 2020
Celiac disease 2020Celiac disease 2020
Celiac disease 2020
 
CELIAC DISEASE by Dr Asad Abbasi.pptx
CELIAC DISEASE by Dr Asad Abbasi.pptxCELIAC DISEASE by Dr Asad Abbasi.pptx
CELIAC DISEASE by Dr Asad Abbasi.pptx
 
Celiac Case Study
Celiac Case StudyCeliac Case Study
Celiac Case Study
 
Chronic diarhea
Chronic diarheaChronic diarhea
Chronic diarhea
 
Celiac.pptx
Celiac.pptxCeliac.pptx
Celiac.pptx
 
Celiac Disease vs Non Celiac Gluten Sensitivity 3
Celiac Disease vs Non Celiac Gluten Sensitivity 3Celiac Disease vs Non Celiac Gluten Sensitivity 3
Celiac Disease vs Non Celiac Gluten Sensitivity 3
 
The Role of Food Sensitivity and Food Intolerance Tests
The Role of Food Sensitivity and Food Intolerance TestsThe Role of Food Sensitivity and Food Intolerance Tests
The Role of Food Sensitivity and Food Intolerance Tests
 
Lewis_Carly_ClinicalCaseStudy
Lewis_Carly_ClinicalCaseStudyLewis_Carly_ClinicalCaseStudy
Lewis_Carly_ClinicalCaseStudy
 
Food intolerence
Food intolerenceFood intolerence
Food intolerence
 
Gluten intolerance and rheumatic diseases 5.2.14
Gluten intolerance and rheumatic diseases 5.2.14Gluten intolerance and rheumatic diseases 5.2.14
Gluten intolerance and rheumatic diseases 5.2.14
 
The Scoop on Gluten Free: Research & Practice Tips
The Scoop on Gluten Free: Research & Practice TipsThe Scoop on Gluten Free: Research & Practice Tips
The Scoop on Gluten Free: Research & Practice Tips
 
celiac disease 0r gluten enteropathy ppty
celiac disease 0r gluten enteropathy pptyceliac disease 0r gluten enteropathy ppty
celiac disease 0r gluten enteropathy ppty
 

More from PathKind Labs

iso 15189 short.pptx
iso 15189 short.pptxiso 15189 short.pptx
iso 15189 short.pptxPathKind Labs
 
behaviour changes for success of antimicrobial stewardship program.pptx
behaviour changes for success of antimicrobial stewardship program.pptxbehaviour changes for success of antimicrobial stewardship program.pptx
behaviour changes for success of antimicrobial stewardship program.pptxPathKind Labs
 
management of childhood tuberculosis in 2023.pptx
management of childhood tuberculosis in 2023.pptxmanagement of childhood tuberculosis in 2023.pptx
management of childhood tuberculosis in 2023.pptxPathKind Labs
 
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptxviral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptxPathKind Labs
 
tackling an invisible pandemic.pptx
tackling an invisible pandemic.pptxtackling an invisible pandemic.pptx
tackling an invisible pandemic.pptxPathKind Labs
 
pk pd of antibiotics.pptx
pk pd of antibiotics.pptxpk pd of antibiotics.pptx
pk pd of antibiotics.pptxPathKind Labs
 
clinical standards for ds tb treatment 2022 (1).pptx
clinical standards for ds tb treatment 2022 (1).pptxclinical standards for ds tb treatment 2022 (1).pptx
clinical standards for ds tb treatment 2022 (1).pptxPathKind Labs
 
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptxwhat is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptxPathKind Labs
 
Seven strategies to prevent hospital associated infections improved.pptx
Seven strategies to prevent hospital associated infections improved.pptxSeven strategies to prevent hospital associated infections improved.pptx
Seven strategies to prevent hospital associated infections improved.pptxPathKind Labs
 
29 nov pct guided antibiotic use
29 nov pct guided antibiotic use29 nov pct guided antibiotic use
29 nov pct guided antibiotic usePathKind Labs
 
Role of neutralizing antibodies in covid 19
Role of neutralizing antibodies in covid 19Role of neutralizing antibodies in covid 19
Role of neutralizing antibodies in covid 19PathKind Labs
 
What is and what is not black fungus and how to diagnose short
What is and what is not black fungus and how to diagnose shortWhat is and what is not black fungus and how to diagnose short
What is and what is not black fungus and how to diagnose shortPathKind Labs
 
24 march short ntep who diagnosis of dr tb
24 march short ntep who diagnosis of dr tb24 march short ntep who diagnosis of dr tb
24 march short ntep who diagnosis of dr tbPathKind Labs
 
18 march what is new in tuberculosis
18 march what is new in tuberculosis18 march what is new in tuberculosis
18 march what is new in tuberculosisPathKind Labs
 
what is new in tuberculosis
what is new in tuberculosiswhat is new in tuberculosis
what is new in tuberculosisPathKind Labs
 
Understanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratoriesUnderstanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratoriesPathKind Labs
 
Essential information on covid 19 vaccinations
Essential information on covid 19 vaccinationsEssential information on covid 19 vaccinations
Essential information on covid 19 vaccinationsPathKind Labs
 
Rapid antigen test when and how
Rapid antigen test when and howRapid antigen test when and how
Rapid antigen test when and howPathKind Labs
 
role serology in diagnosis and control of covid 19 short
 role serology in diagnosis and control of covid 19 short role serology in diagnosis and control of covid 19 short
role serology in diagnosis and control of covid 19 shortPathKind Labs
 

More from PathKind Labs (20)

iso 15189 short.pptx
iso 15189 short.pptxiso 15189 short.pptx
iso 15189 short.pptx
 
behaviour changes for success of antimicrobial stewardship program.pptx
behaviour changes for success of antimicrobial stewardship program.pptxbehaviour changes for success of antimicrobial stewardship program.pptx
behaviour changes for success of antimicrobial stewardship program.pptx
 
management of childhood tuberculosis in 2023.pptx
management of childhood tuberculosis in 2023.pptxmanagement of childhood tuberculosis in 2023.pptx
management of childhood tuberculosis in 2023.pptx
 
iso 15189.pptx
iso 15189.pptxiso 15189.pptx
iso 15189.pptx
 
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptxviral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
 
tackling an invisible pandemic.pptx
tackling an invisible pandemic.pptxtackling an invisible pandemic.pptx
tackling an invisible pandemic.pptx
 
pk pd of antibiotics.pptx
pk pd of antibiotics.pptxpk pd of antibiotics.pptx
pk pd of antibiotics.pptx
 
clinical standards for ds tb treatment 2022 (1).pptx
clinical standards for ds tb treatment 2022 (1).pptxclinical standards for ds tb treatment 2022 (1).pptx
clinical standards for ds tb treatment 2022 (1).pptx
 
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptxwhat is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
 
Seven strategies to prevent hospital associated infections improved.pptx
Seven strategies to prevent hospital associated infections improved.pptxSeven strategies to prevent hospital associated infections improved.pptx
Seven strategies to prevent hospital associated infections improved.pptx
 
29 nov pct guided antibiotic use
29 nov pct guided antibiotic use29 nov pct guided antibiotic use
29 nov pct guided antibiotic use
 
Role of neutralizing antibodies in covid 19
Role of neutralizing antibodies in covid 19Role of neutralizing antibodies in covid 19
Role of neutralizing antibodies in covid 19
 
What is and what is not black fungus and how to diagnose short
What is and what is not black fungus and how to diagnose shortWhat is and what is not black fungus and how to diagnose short
What is and what is not black fungus and how to diagnose short
 
24 march short ntep who diagnosis of dr tb
24 march short ntep who diagnosis of dr tb24 march short ntep who diagnosis of dr tb
24 march short ntep who diagnosis of dr tb
 
18 march what is new in tuberculosis
18 march what is new in tuberculosis18 march what is new in tuberculosis
18 march what is new in tuberculosis
 
what is new in tuberculosis
what is new in tuberculosiswhat is new in tuberculosis
what is new in tuberculosis
 
Understanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratoriesUnderstanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratories
 
Essential information on covid 19 vaccinations
Essential information on covid 19 vaccinationsEssential information on covid 19 vaccinations
Essential information on covid 19 vaccinations
 
Rapid antigen test when and how
Rapid antigen test when and howRapid antigen test when and how
Rapid antigen test when and how
 
role serology in diagnosis and control of covid 19 short
 role serology in diagnosis and control of covid 19 short role serology in diagnosis and control of covid 19 short
role serology in diagnosis and control of covid 19 short
 

Celiac disease diagnosis algorithm

  • 1. Food Allergy & Food Intolerance Diagnostic algorithm for Celiac Disease Dr Ashok Rattan, MD, MAMS Chief Operating Officer & Medical Director, Star Metropolis Clinical Lab Dubai, Sharjah, Abu Dhabi
  • 2. Diagnostic Algorithm for Celiac Disease Food Allergy Vs Food intolerance
  • 3. Definition of Food Allergy ? Definition of Food Allergy Food allergy has no universally accepted definition. The NIAID has suggested that food allergy be defined as •“Adverse immune response that occurs reproducibly on exposure to a given food and is distinct from other adverse responses to food, such as, food intolerance, pharmacologic reactions or toxin mediated reactions”
  • 4.
  • 5.
  • 6.
  • 7. Signs & Symptoms of Food Allergy ATOPY Type 1 Hypersensitivity
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 18.
  • 19.
  • 20. Food allergy & “Intolerance” Type of Reaction Cause Food Involved Allergy Atophy, IgE mediated Eggs, Milk, Wheat, Fish, Shellfish, Nut, Peanuts, Soya Pharmacological Absorption of certain amines from food Fermented food (cheese, red wine, sausages) fish Enzyme defects Failure of normal enzymatic breakdown after absorption Methanol, Lactose Irritant Reflux Strong spices Toxic Toxins Some shellfish, Mushroom, badly stored food Chemicals MSD, Sulfites Chinese food, dry fruits Celiac disease IgG to Gliadin, auto-immune Wheat, Maize, Rye Psychological Emotional reaction to food
  • 21. Food proteins are recognized as “foreign” Food specific IgG production and formation of antigen/antibody complexes Complexes are deposited in tissues and activate Complement Complement and macrophages stimulate Inflammation Delayed reaction and may last for days
  • 23. Signs & Symptoms of Food Intolerance
  • 24.
  • 25.
  • 26.
  • 27. Class 0 Classes 1-2 No allergic reaction against tested food. No restriction is necessary. Means that there is a low to moderate allergic reaction against tested food. These have to be avoided for 12 weeks. Class 3 There is a major allergy type III against the tested foods. Strict avoidance for 6 months. Class 4 There is a major allergy type III against the tested foods. Strict avoidance for 1 year.
  • 28.
  • 29.
  • 30. Improvement of symptoms (%) after omitting allergenic food Study, 2002-2008; evaluated by Mediveritas Institiute for Medical Studies, Munich 30
  • 31.
  • 32.
  • 33. Celiac Disease • Samuel Gee (1888) first described Celiac disease in “On the Coelic Affection” – Gluten sensitive entropathy – Nontropical sprue • Aretaeus from Cappadocia (now Turkey) described similar malabsorption disorder in second century AD
  • 34. Celiac disease “There is a kind of chronic indigestion which is met with in persons of all ages, yet is especially apt to affect children between one and five years old . Signs of the disease are yielded by the fæces; being loose, not formed, but not watery; more bulky than the food taken would seem to account for; pale in colour, as if devoid of bile; yeasty, frothy, an appearance probably due to fermentation; stinking, stench often very great, the food having undergone putrefaction rather than concoction".
  • 35. What is celiac disease ? • Chronic inflammatory disease primary affecting small intestine • Results from inflammatory response initiated by dietary gluten • Inflammation leads to damage and atrophy of intestinal villae
  • 36. Clinical features Consequence of intestinal inflammation & atrophy • Common clinical symptoms – Abdominal pain – Diarrhea / vomiting nonspecific – Failure to thrive/malnutrition • Comorbid conditions – Immunologic abnormalities • Selective IgA deficiency – Autoimmune endocrine disorders • Type 1 diabetes – Dermatologic disorders
  • 39.
  • 40. Celiac Disease can present at ANY age to ANY specialty Farrell RJ & Kelly CP: New Engl J Med 2002; 336: 180 - 188
  • 41. Cause of celiac disease • Willem K Diche recognized association between consumption of bread & relapsing diarrhoea • WW 2: unconventional, non-cereal foods – Fruits, potatoes, banana, milk or meat • After WW 2, symptoms reappeared
  • 44.
  • 45. Role of tTG in Celiac Disease
  • 47.
  • 48. HLA & Celiac Disease Useful for ruling out celiac disease
  • 49. Development of celiac disease • Environmental component – Exposure to cereal grain proteins • Wheat, barley, rye [gluten] • Genetic component – Family members of individuals – HLA DQ 2 or HLA DQ 8
  • 50.
  • 53. Dermatitis Herpetiformis (Duhring’s disease) • • • • • • • Chronic blistering skin condition No virus involved Autoantibodies present, gluten intolerance Affects both male & females, 15 to 40 yrs of age Intensively itchy, chronic papulo-vesicular rash EMA positive (IFA): Ig A isotype eTG (epidermal Transglumase) positive IgG / IgA • HLA DQ 2
  • 54. Ciliac Disease Histopathology Normal small bowel mucosa Small bowel mucosa in celiac disease showing subtotal villus atrophy.
  • 55. Diagnosis • Presumptive diagnosis – Positive serology – Intestinal biopsy with villous atrophy • Definitive diagnosis – Resolution of clinical symptoms after initiation of gluten free diet • Generally accompanied by conversion to negative serology & reconstitution of villi
  • 56. Laboratory Diagnosis of Celiac Disease Milestones • Before 1960: based on clinical suspicion & biopsy • 1982: Anti gliadin; Sensitivity: 70%; Specificity 70% • 1985: Endomysial IFA; Sen: 70 – 90%; Specificity 100% • 1997: Anti tTG by ELISA; Sen & Spec: 90 – 95% • 2005: Anti deamidated Gliadin: Sen: 85%, Spec 90%
  • 57. Serologic tests for celiac disease 2014 • Tissue transglutaminase antibodies – IgA and IgG isotypes [ELISA] • Deamidated gliadin antibodies – IgA and IgG isotypes [ELISA] • Endomysial antobodies – IgA isotype only by IFA
  • 58. Other investigations • HLA DQ typing • Small intestinal biopsy • Total IgA
  • 59.
  • 60. Test for selective IgA deficiency
  • 61. 1. Normal Total IgA CD unlikely HLA DQ2 & DQ8 Negative Deamidated Gliadin IgA & IgG EMA IgA +/+, +/-,-/+ -/- Positive CD unlikely S.I Biopsy
  • 62. 2. IgA detectable but below RR HLA DQ 2 & DQ 8
  • 63. 3. Undetectable Total Ig A • Selective IgA deficiency • Test for tTG • Test for Deamidated Gliadin – Both for IgG isotype only • If positive advice small intestinal biopsy
  • 64.
  • 65.
  • 66. Summary • Total IgA – Identify individuals with selective IgA deficiency • Anti TTG & Anti deamidated gliadin antibodies • IgA & IgG isotypes • Anti EMA IgA isotype by IFA • Identify individuals with suspected celiac disease • Confirm with small intestine biopsy – Specific antibodies may be absent if on gluten free diet • HLA DQ 2 & HLA DQ 8 – Negative results virtually excludes diagnosis of CD
  • 67. Additional tests that need to be carried out • • • • • • • • CBC TSH LFT Vitamins: D, A, E, K, Folate, B12 Calcium, Phosphate, Zinc PTH Iron studies Bone Mineral Density Scan
  • 68. Who should be tested ? Rubio Tapia R et al: Am J Gastro 2013: 108: 656 – 76 American Gastroenterology Society Recommendations • Consider testing in symptomatic patients at high risk of – Autoimmune Hepatitis – Premature onset osteoprosis – Primary Biliary cirrhosis – Unexplained increase in liver transaminases – Unexplained iron deficiency anemia • Consider testing for CD when following are present: – Autoimmune Thyroid disease – Cerebellar Ataxia – 1st & 2nd degree relatives – IBS – Peripheral neuropathies – Selective IgA deficiency – Type 1 diabetes – Turner & Down syndrome
  • 69. Who should be tested ? ESPGHAN Guidelines for Celiac Disease 2012 European Society for pediatric gastroenterology, hepatology and nutrition • Group 1 – Children & adolescents with otherwise unexplained symptoms & signs of • Chronic or intermittent diarrhea • Failure to thrive / Weight loss/ Stunted growth • Delayed puberty / Amenorrhea • Iron deficiency anemia • Nausea or vomiting • Abdominal pain, cramping or distention • Chronic fatigue • Recurrent aphthous ulcer • Group 2 – Asymptomatic children & adolescent with • Type 1 diabetes • Down syndrome • Autoimmune thyroid disease • Turner syndrome • Selective IgA deficiency • Autoimmune liver disease • First degree relatives of Celiac disease patients
  • 70. A simple scoring system ESPGHAN Guidelines for Celiac Disease 2012 European Society for pediatric gastroenterology, hepatology and nutrition Elements (Need Score of 4 for diagnosis) Score Symptoms: Malabsorption Other CD relevant symptoms or TIDM or 1st degree relative Asymptomatic 2 1 0 Serum antibodies EMA positivity and/or high positivity for anti tTG Low positivity for tTG or isolated anti DGP positivity Serology not performed Serology performed but all celiac specific antibodies negtive 2 1 0 -1 HLA Full HLA DQ 2 or HLA 8 hetrodimer present No HLA performed or half DQ 2 present HLA neither DQ 2 or DQ 8 1 0 -1 Histology Marsh 3b or 3c (subtotal villous atrophy, flat lesion) Marsh 2 or 3a (moderate decreased villous height) plus tTG antibodies Marsh 0 – 1 or no biopsy performed 2 1 0
  • 71. One man’s alloo paratha maybe another man’s poison
  • 72. Caution ESPGHAN Guidelines for Celiac Disease 2012 European Society for pediatric gastroenterology, hepatology and nutrition • A gluten free diet (GFD) should be introduced only after the completion of the diagnostic process and when a conclusive diagnosis has been made. • Healthcare professionals should be advised that starting patients on a GFD, when CD has not been excluded or confirmed, may be detrimental.